According to Dr. Reddy's's latest financial reports the company's current earnings (TTM) are $0.85 B. In 2022 the company made an earning of $0.71 B an increase over its 2021 earnings that were of $0.49 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.85 B | 19.7% |
2022 | $0.71 B | 43.38% |
2021 | $0.49 B | 31.44% |
2020 | $0.37 B | 54.02% |
2019 | $0.24 B | -12.03% |
2018 | $0.27 B | 23.32% |
2017 | $0.22 B | 4.71% |
2016 | $0.21 B | -55.57% |
2015 | $0.48 B | 1.4% |
2014 | $0.48 B | -3.52% |
2013 | $0.49 B | 53.87% |
2012 | $0.32 B | -16.12% |
2011 | $0.38 B | 56.72% |
2010 | $0.24 B | -235.77% |
2009 | -$0.19 B | -197.98% |
2008 | $0.18 B | 30.89% |
2007 | $0.14 B | -14.94% |
2006 | $0.16 B | 703.89% |
2005 | $20.67 M | 645.22% |
2004 | $2.77 M | -95.29% |
2003 | $58.86 M | 35.36% |
2002 | $43.48 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | 1,005.21% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | 282.57% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | 883.11% | ๐ซ๐ท France |
GlaxoSmithKline GSK | $7.53 B | 782.37% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $0.40 B | -52.57% | ๐ฎ๐ฑ Israel |